Skip to Main Content

Hematopoietic Stem/Progenitor Cell Fate Specification in Health and Disease

September 25, 2020
  • 00:00OK, so welcome. I'm going to be
  • 00:03talking about hematopoietic stem and
  • 00:05progenitor cell fate specification
  • 00:06in health predominantly and disease
  • 00:08and I just loved megakaryocytes,
  • 00:11so I have a picture of a gorgeous
  • 00:13megakaryocyte here you can see all of
  • 00:16the nuclei inside this megakaryocyte.
  • 00:18This megakaryocyte became polyploid
  • 00:19in vitro, so the nuclei,
  • 00:21or separate and abstained the cytoskeleton.
  • 00:24The actin and tubulin and you can
  • 00:26just see how gorgeous these cells are.
  • 00:30So I have to be able to go forward.
  • 00:33There we go.
  • 00:34So this is just the hematopoietic tree
  • 00:36for anybody who is new to him out of
  • 00:39police is these are hematopoietic stem cells.
  • 00:42They divide and differentiate,
  • 00:44become hematopoetic progenitor cells and
  • 00:46then the classic tree shows that they
  • 00:48split into common lymphoid progenitors,
  • 00:50which will make the B&T cells and NK cells
  • 00:52and Common myeloid progenitor cells,
  • 00:55amongst which then you get me
  • 00:57P Mega Rich Royd Projectors,
  • 00:59which is what I'll be focusing on today.
  • 01:02Since it's bright orange
  • 01:03granulocyte monocyte for janitors,
  • 01:04the maker annulus sites and monocytes
  • 01:07and these mega rich right for janitors
  • 01:09that make the megakaryocytes and
  • 01:11are it's red cells and we produce
  • 01:13about 2 * 10 to the 11th.
  • 01:15New platelets and red blood cells daily,
  • 01:18and if you calculate that down it's
  • 01:20about 2 million platelets in 2
  • 01:22million red cells at every second.
  • 01:24So these MVP are very,
  • 01:26very busy and we'd like to better
  • 01:28understand how the MVP Self Renew
  • 01:30and choose a fate to become.
  • 01:32With Droid Versus Megakaryocytic.
  • 01:35This image just shows that there
  • 01:37are over 14 million platelet
  • 01:38transfusions worldwide annually,
  • 01:40which we would like to be able
  • 01:42to decrease the need for donors.
  • 01:45An if there were ways of making
  • 01:47platelets in vitro that would be
  • 01:49great and this is from an excellent
  • 01:52video that might all talk will
  • 01:54be available on YouTube later.
  • 01:56Jonathan has a video of Platelet formation
  • 01:58and this these images are from that.
  • 02:01It's spectacular.
  • 02:02I highly recommend it.
  • 02:03OK,
  • 02:03so why do we study the megakaryocyte?
  • 02:06Erythroid progenitor or me P,
  • 02:08which makes Mega Mega Carey site
  • 02:11progenitors which make megakaryocytes
  • 02:13and platelets and erythroid
  • 02:14progenitors that make red blood cells.
  • 02:17So we studied this for lots of
  • 02:19reasons and you guys could probably
  • 02:21come up with additional good ones.
  • 02:23But first of all it just by
  • 02:25learning how the MVP makes it date,
  • 02:27it's fate.
  • 02:28Decisions were learning really about
  • 02:29cell fate decisions in general,
  • 02:31basics of stem cell biology,
  • 02:32what makes us Ella stem cell?
  • 02:34What makes a cell at progenitor cell,
  • 02:36and how does it make its fate?
  • 02:39Decisions for regenerative medicine purposes,
  • 02:40it's good to understand how this
  • 02:42actually occurs in vivo,
  • 02:43so that we can improve our
  • 02:45approaches for making platelets
  • 02:47and red blood cells in vitro.
  • 02:48For patients,
  • 02:49and also because understanding this
  • 02:52entire lineages and how it's regulated
  • 02:55will lead to the discovery of potential
  • 02:58targets for disorders of the Mega.
  • 03:00Carey's itinerary thread lineages.
  • 03:02So how can one distinguish an
  • 03:04Emmy PA megathread progenitor
  • 03:06cell functionally in FINA?
  • 03:07Typically this is a challenge that
  • 03:10was initially taken up by Ched Sonata
  • 03:12when he was a postdoc in my lab,
  • 03:14and then followed up by
  • 03:16Juliana Javie Ferruccio,
  • 03:17who then finish the work and what
  • 03:19they did is they figured out a way
  • 03:21where you start with a single cell.
  • 03:24You hope it's a mega rich Rd progenitor,
  • 03:26and if you keep that cell in
  • 03:29culture for about 2 weeks,
  • 03:30it will form a colony of cells where
  • 03:33the only cells in that colony.
  • 03:35Are megakaryocytes and red blood cells,
  • 03:37so this is this was the goal and this is
  • 03:40what Chad and you figured out how to do.
  • 03:43So basically what they would
  • 03:45do is fax sort candidate MPs,
  • 03:47megathread progenitor cells and
  • 03:48put them into semisolid media.
  • 03:50Very, very seriously.
  • 03:51So none of the two colonies would
  • 03:53be bumping up against each other
  • 03:56and then waited 13 to 15 days and
  • 03:58at the end of that period they
  • 04:00stained with antibodies.
  • 04:01They staying with an antibody
  • 04:03against Glycophorin A,
  • 04:04which is a red blood cell antigen.
  • 04:06And again CD41A,
  • 04:07which is on Maggie Carey sites and
  • 04:09you can see we have some colonies
  • 04:12that are erythroid only and some
  • 04:14colonies that are Mega Carey site
  • 04:15only and then we have some colonies
  • 04:18that have both colors in them and
  • 04:20these are colonies that we can see.
  • 04:22If you mke because they have both
  • 04:25megakaryocytes and erythrocytes.
  • 04:26So using this functional readout
  • 04:28for a by potent progenitor chat and
  • 04:31then shoe went through Facs sorting
  • 04:33protocols to try to identify the best
  • 04:36enrichment they could for primary
  • 04:38human megathread progenitors and
  • 04:40what they discovered is if you gate
  • 04:43within the 34 positive Lynn negative 135.
  • 04:45That's all three receptor negative CD,
  • 04:4845 RA negative population.
  • 04:49If you look for Maple,
  • 04:51which is the receptor for thrombo
  • 04:53poet and the vast majority of
  • 04:56these cells are Maple positive.
  • 04:58It's not limited to megakaryocytes,
  • 05:00we know he mad about extending
  • 05:02projector cells expressed nipple,
  • 05:03but then there was also this nipple
  • 05:06low population and if we look at that
  • 05:09and compared to excuse me CD 38 which
  • 05:11I'm sorry that should be labeled better.
  • 05:14What we can find is that the
  • 05:16erythroid progenitors tend to have
  • 05:18less nipple and more CD 38 so
  • 05:20if we enrich for this population
  • 05:22they grow erythroid only colonies.
  • 05:24If you then take this population which
  • 05:27is really in the middle for 3038,
  • 05:29it's not the most negative and
  • 05:31it's not the most positive.
  • 05:33And then you get on CD 41.
  • 05:35You can find CD 41 positive Meg
  • 05:38progenitors that make Mega Carey
  • 05:39site only colonies and these MVP,
  • 05:41which made colonies that have
  • 05:44both Meg Anorith Royd cells.
  • 05:46When they enriched for these populations,
  • 05:48this is what the colonies look like,
  • 05:51and you'll see a lot of these
  • 05:53graphs in my talk,
  • 05:55so I'm going to go through this slowly.
  • 05:57What I'm showing you here on
  • 05:59the Y axis is
  • 06:00the number of colonies per 100 cells plated,
  • 06:03and what I'm showing you in blue is the
  • 06:06number of those colonies that had both
  • 06:08megakaryocytes and erythrocytes in them,
  • 06:10so a by potent colony and you can see
  • 06:13about half of the colonies that grow.
  • 06:16Have megakaryocytes and erythrocytes and E.
  • 06:18Only colony has just erythrocytes and a Meg.
  • 06:21Only colony has just megakaryocytes.
  • 06:23We also enriched as I said for Meg
  • 06:26Progenitors which are in the CD 41
  • 06:29positive population and erythroid
  • 06:31progenitors which are in the.
  • 06:33Nipple low population that has more CD 38.
  • 06:36So we were able to enrich for these cells.
  • 06:39We always get some erythroid, only an MB.
  • 06:42Only colonies in our cultures of MVP.
  • 06:44So one of our questions is really,
  • 06:46is this a uniform population where by
  • 06:49chance some of the colonies will be
  • 06:51erythroid only and some will be Meg only?
  • 06:54Or we really contaminated here
  • 06:55with some erythroid progenitors and
  • 06:57some Meg progenitors.
  • 06:58So what we next did is to better
  • 07:00understand this Anne how fake
  • 07:02decisions actually occur is performed.
  • 07:04Single cell RNA seq on the
  • 07:06different populations in this work.
  • 07:08Was done by Yishun,
  • 07:09or will Lou in my laboratory.
  • 07:12So what he did is he fax sorted out the
  • 07:15candidate Mega Rich Ride Projectors.
  • 07:18The Meg Progenitors the erythroid
  • 07:20progenitors and then the upstream
  • 07:21common myeloid progenitors,
  • 07:23and this was done with single cell seq
  • 07:26that was run by Amazong in the Yale
  • 07:29stem cell center or genomics core.
  • 07:32The data were then analyzed with
  • 07:33the assistance of Nathan Salamone's
  • 07:35at University Cincinnati,
  • 07:36and I want to take a minute to
  • 07:38really look at this heat map,
  • 07:40'cause it gave us a lot of information.
  • 07:42That was some of it quite surprising.
  • 07:45So what you can see here is these are
  • 07:47single cells from top to bottom that are
  • 07:49from the common myeloid progenitor gate.
  • 07:52These are single cells from the
  • 07:53Mega Rich Royd Projector Gate.
  • 07:55These are cells from the megakaryocyte
  • 07:57progenitor gate and the erythroid
  • 07:58progenitor gate and what you can
  • 08:00see is there are distinct gene
  • 08:02expression patterns that are unique.
  • 08:03To arrest rate for janitors.
  • 08:05Jeans are from left to right here.
  • 08:07So these are genes that are expressed
  • 08:09uniquely in Eryth Roid Progenitors.
  • 08:11These are genes that are expressed
  • 08:13uniquely in Meg progenitors.
  • 08:14Mazer jeans that are expressed
  • 08:16predominantly in common myeloid progenitors.
  • 08:18But there's no such group of jeans
  • 08:20for the Mega Mega Carey Cider
  • 08:22Ridge Rd for generators.
  • 08:24They really seem to be a
  • 08:26transitional population.
  • 08:26That's between the CMP where some
  • 08:28of the CMP jeans are still on,
  • 08:31but they're all going to turn
  • 08:33off when they be picked.
  • 08:34A fate to be Mega Rich,
  • 08:36Royd,
  • 08:37and then you see some that are
  • 08:39me P an MB only,
  • 08:40and some that are me P Anorith Droid only,
  • 08:43and what that taught us is that
  • 08:45MVP really are a unique population.
  • 08:48They are not contaminated
  • 08:49with Meg Progenitors.
  • 08:50'cause these jeans are
  • 08:51not on yet and they're not
  • 08:53contaminated with the rich Roy Projectors.
  • 08:55They really are at their own
  • 08:57unique population that has a
  • 08:59little bit of expression of E.
  • 09:01Only jeans, MK only jeans,
  • 09:03and some leftover from this
  • 09:04common myeloid progenitor.
  • 09:05So true transitional population.
  • 09:08And we wanted to then look at the
  • 09:10specific genes that turn on and off and
  • 09:13understand whether the fate decisions
  • 09:14are made according to what had been
  • 09:17classic dogma in the literature.
  • 09:19So the classic dug in the literature
  • 09:21is than any pee pics to be a
  • 09:23mega Carey Cider Inner it's roid
  • 09:25commitment by expression of KLF one,
  • 09:27or flee once OK LF one is also
  • 09:30known as a rich Rd krupa like
  • 09:32factor or E KLF and flea one is a
  • 09:35transcription factor that is known
  • 09:37to be necessary for Meg progenitors.
  • 09:39To differentiate into megakaryocytes so when
  • 09:41we looked at the gene expression of these,
  • 09:43we thought we would find is that
  • 09:45these cells are uniquely flea.
  • 09:47One positive these cells are uniquely
  • 09:49KLF one positive and these cells
  • 09:51pick one or the other, or neither.
  • 09:53But that's not what we got.
  • 09:54Oh, and it's already been shown.
  • 09:56I'm sorry in the dogma that
  • 09:58fully one turns off KLF one.
  • 10:00Tail F1 turns awfully one in cell lines,
  • 10:03but when we looked at the gene expression
  • 10:05patterns of all the various gene patterns,
  • 10:07we could have jeans that are on and
  • 10:09then off and the other lineages,
  • 10:11or often CMP in them on in
  • 10:13the other lineages,
  • 10:14we found that there were very few
  • 10:17transcription factors that really
  • 10:18told us the story to as to how
  • 10:20these state decisions are made.
  • 10:22So just looking at flea one and KLF
  • 10:24one what you can see is now what
  • 10:26I've done is from the heat map.
  • 10:29We still have.
  • 10:29These are individual CMP's individual MPs,
  • 10:31individual Meg progenitors and
  • 10:32individual rich Rd projectors.
  • 10:34And these are comb plots of individual genes,
  • 10:37so KLF one.
  • 10:38As you can see,
  • 10:39is expressed in some me P in
  • 10:41some Meg progenitors.
  • 10:42It's predominantly expressed
  • 10:43in the erythroid progenitors,
  • 10:45but it's really not showing you that it's
  • 10:48clearly making a fate decision of any sort.
  • 10:50Flea.
  • 10:51One is also expressed in almost
  • 10:53every Lenny Edge at well.
  • 10:55Yes,
  • 10:55it is expressed strongly in Meg Progenitors.
  • 10:57It's also expressed throughout MVP,
  • 10:59and if you look for Co expression
  • 11:02of flea one and KLF one in MVP.
  • 11:04Sometimes it is coexpressed in,
  • 11:06sometimes it's not,
  • 11:07so it wasn't quite so simple.
  • 11:08We also looked at Gotta One and
  • 11:10got it two which are known to
  • 11:12be critical for a rich Rd in
  • 11:14megakaryocytic maturation.
  • 11:15And what you can see is that gotta
  • 11:17one comes on when the cells commit
  • 11:19to the megathread progenitor
  • 11:20lineages and then stay on.
  • 11:21In both lineages got it too is
  • 11:24expressed throughout as his NFE 2.
  • 11:26So what really is going on and
  • 11:28what's making these fate decisions?
  • 11:29We looked at all of the different
  • 11:32gene expression patterns and
  • 11:33found some pretty interesting
  • 11:34genes and genes that are
  • 11:36somewhat me specific that we're
  • 11:37pursuing further in my lab.
  • 11:39But really, what the data ended
  • 11:41up showing is that it's not one
  • 11:43specific group of jeans I wanted
  • 11:45to make sure to stop and say again,
  • 11:48this is going to be.
  • 11:50Publicly available on YouTube at
  • 11:52this URL that I have down here and
  • 11:54it's also available in the paper,
  • 11:56you can actually put any gene
  • 11:58of interest in an get the comb
  • 12:00plots that you're interested in
  • 12:02from the are single cell data.
  • 12:04OK, So what ended up happening is
  • 12:06when we analyze these data using gene
  • 12:08ontogeny and other approaches is
  • 12:10the cell cycle was amongst the most
  • 12:12the genes of the cell cycle where
  • 12:14the most differentially expressed.
  • 12:15When you compared me, PETA,
  • 12:17Meg progenitors and me Peter
  • 12:19it's red projectors.
  • 12:20You can see regulation of the
  • 12:21cell cycle comes up here and then.
  • 12:24All of these different differences
  • 12:25between MVP and MKP and this actually
  • 12:27kind of hit a nerve with us 'cause
  • 12:30we already had a finding that
  • 12:32suggested this might be the case.
  • 12:34What we already knew.
  • 12:35We had tried some candidate
  • 12:37drugs to see if we could.
  • 12:39If they affect the Mega Rich Rd
  • 12:40fate decision and we had added for
  • 12:42example all trans retinoic acid
  • 12:44at low and high concentrations and
  • 12:46seeing a dose dependent increase in
  • 12:48megakaryocyte fate specification.
  • 12:49Similarly with Rappo Mison with a dose
  • 12:51dependent increase in Meg fate specification.
  • 12:53And this was true for a lot of other
  • 12:55drugs that we had tried that were
  • 12:58known kinase inhibitors and what
  • 12:59became clear to us is the thing
  • 13:01that all of these inhibitors had.
  • 13:03All of these drugs head is that they inhibit.
  • 13:06Or slowed the cell cycle.
  • 13:07So we decided to test that.
  • 13:09So what we've done here is just
  • 13:12treating with all trans retinoic acid,
  • 13:14the 50 nanomolar,
  • 13:15which is the same thing is down
  • 13:17here you take any pee,
  • 13:19stain them with CFC and then as
  • 13:21the cells are in culture for
  • 13:2372 hours that CFC gets diluted.
  • 13:25So from as cells become lower in
  • 13:28their fluorescence for CFC that means
  • 13:30that they have proliferated more
  • 13:31times and what you can see is the
  • 13:34control population or blue population here.
  • 13:36Has proliferated more times than
  • 13:38the population that was treated
  • 13:40with Aptra and which gave you a
  • 13:41Meg lineages bias suggesting that
  • 13:43this lower cell cycle might be
  • 13:45associated with the Meg bias.
  • 13:47Similarly with Rappa Mice and we see
  • 13:49a slower cell cycle that's shown here
  • 13:51in red is associated with the Meg bias.
  • 13:54So what we did is we tested just
  • 13:56inhibiting the cell cycle with
  • 13:58the CD K46 Inhibitor and here you
  • 14:00can see that the cells that were
  • 14:02treated with the inhibitor or
  • 14:04practically not dividing at all,
  • 14:06whereas the control population is Dividing.
  • 14:08And again we see a dose.
  • 14:10Specific increase in the Meg
  • 14:12progenitor cell fate decision.
  • 14:14So the next thing we had to do
  • 14:16is figure out a way to increase
  • 14:19this cell cycle speed,
  • 14:20and for this we ended up trying
  • 14:23to knock down CD 21 and CD 57,
  • 14:25but those things didn't work very well.
  • 14:28They killed the cells so we
  • 14:30tried something else and what we
  • 14:32did is from the Vascular lab.
  • 14:34We got two different constructs.
  • 14:36One is C DK2 cycle independent,
  • 14:38two cyclin dependent kinase
  • 14:39to driving cycling.
  • 14:40E phosphorylation and cycling depending
  • 14:42kinase for which promotes cycling.
  • 14:44D phosphorylation,
  • 14:45and we coexpressed either CD K2 and
  • 14:48Cyclin E or C DK foreign cyclin
  • 14:50D in our MVP and what you can
  • 14:53see up here is for the site CD.
  • 14:55K for Cyclin D, which we call for.
  • 14:58D actually promotes G one of the cell
  • 15:01cycle and CK2 Cyclin E which we call
  • 15:042 E promotes the G1 to S transition and down.
  • 15:07Here we can see the data the two E.
  • 15:11And four deconstructs gave
  • 15:12us Anorith Royd Bias,
  • 15:13which is what we were looking for.
  • 15:15It's the opposite of the Meg bias that
  • 15:17we get when we slowed the cell cycle.
  • 15:20When you just had to Ian 40 to Meg
  • 15:22progenitors in Eryth Roid Progenitors,
  • 15:24you don't see any specific change
  • 15:26in their fate specification.
  • 15:27And up here,
  • 15:28we're just showing that when you
  • 15:30overexpress the 2E or 4D in the cells,
  • 15:32you get a faster cell cycle,
  • 15:34or the CFC is more diluted.
  • 15:35So this really suggested to us
  • 15:37that the faster cell cycle is
  • 15:39associated with the River police is.
  • 15:41Slower cell cycle with Mega Carey
  • 15:43side of Louise is so can we assess
  • 15:46cell cycle in vivo and now I'm bout
  • 15:48to present to you some unpublished
  • 15:50work using and now recently published
  • 15:53fluorescent Reporter mouse.
  • 15:54They shun ching glow at Yale University
  • 15:56has developed and what she did is
  • 15:59she made a mouse that basically
  • 16:01tells you the cell cycle speed of
  • 16:03any given cell that you look at.
  • 16:05She did this by overexpressing a cell
  • 16:08cycle timer protein that starts out
  • 16:10blue and then gradually becomes red overtime.
  • 16:13And this has been described previously.
  • 16:15She fused it with Histone
  • 16:16H2B so it was nuclear.
  • 16:18And what you can see in the math is
  • 16:20all in this paper that's available
  • 16:22in bio archive soon to be out
  • 16:25in a peer reviewed publication.
  • 16:27Basically what happens is the blue
  • 16:29because it is expressed for just
  • 16:31a short time after the protein
  • 16:33comes on is always steady,
  • 16:35whereas the red gets brighter and
  • 16:37brighter and brighter as as the cell.
  • 16:40Proliferates So what you can see is
  • 16:42if you look at the blue red ratio
  • 16:44you get a sense of how quickly
  • 16:46that cell has been proliferating.
  • 16:48So when we did this and I think the
  • 16:51main thing here is to look down here,
  • 16:53I'll tell you what we did.
  • 16:55What we did is we took urine cells from
  • 16:58these Reporter Mice and we gated on them.
  • 17:00You Ring me pee Meg.
  • 17:02Progenitor eryth roid for genitor
  • 17:04or fully differentiated cells that
  • 17:06were Lynn positive and then for
  • 17:08every cell we looked
  • 17:09at the ratio of blue to red.
  • 17:11If you have a lot of red,
  • 17:13so a high red to blue ratio,
  • 17:15that means you're proliferating much,
  • 17:17much faster and what you can see is that the
  • 17:19erythroid cells the erythroid progenitors
  • 17:21are the fastest cells in the proliferation.
  • 17:24The Meg progenitors were in the middle.
  • 17:26And the MVP,
  • 17:27the by potent progenitors upstream,
  • 17:29where the slowest.
  • 17:30So this was new information to us,
  • 17:32although it was consistent with
  • 17:33what we've seen in vitro for human
  • 17:36cells is that MVP are probably
  • 17:37the slowest proliferating cells,
  • 17:39then the Meg progenitor cells,
  • 17:40then the erythroid progenitor cells.
  • 17:42So our model right now is that
  • 17:44me PR is quite slow.
  • 17:46They do self renew and then
  • 17:47if you pick up the cell cycle,
  • 17:50so it's a little faster than that,
  • 17:52you're a Meg progenitor and a faster
  • 17:54cell cycle, Anorith raid progenitor.
  • 17:56And we haven't.
  • 17:57Still answered the question
  • 17:58as to how this happens.
  • 18:00That's a really,
  • 18:01really exciting,
  • 18:02important question.
  • 18:02We think there are lots of things
  • 18:05going on in addition to maybe
  • 18:07epigenetic things with DNA methylation.
  • 18:09There are probably also changes
  • 18:11in phosphorylation of critical
  • 18:13transcription factors when you
  • 18:15have a slower fast cell cycle.
  • 18:17So I'm going to move on to now is
  • 18:20whether there are clinical scenarios
  • 18:22in patients where MP fate might
  • 18:24play a critical role and this
  • 18:26is work that was done again bij
  • 18:28Juliana Javie Ferruccio and now in
  • 18:30collaboration with Vanessa Scanlon,
  • 18:32an instructor in my laboratory and
  • 18:34what we're looking at is iron deficiency.
  • 18:36So it's long been known anecdotally,
  • 18:38the patients who become iron deficient
  • 18:40have elevated platelet counts,
  • 18:42and we decided we really wanted
  • 18:44to look at that and see whether
  • 18:46it might be an MVP fake decision.
  • 18:49So what you're seeing here is just
  • 18:51data from published accounts of
  • 18:53patients with iron deficiency anemia,
  • 18:55specifically in.
  • 18:57Um Irida, which I'll tell you bout,
  • 19:00which is a temporal 6 Mutation population,
  • 19:03but they're highly iron deficient and.
  • 19:06Refractory to when you add iron.
  • 19:08So iron refractory iron deficiency
  • 19:10anemia and what you can see is
  • 19:13in individual patients.
  • 19:14These are 11 of individual patients.
  • 19:16As the hemoglobin goes down,
  • 19:18the platelet count goes up.
  • 19:20So if we could look at the
  • 19:22MVP in these patients,
  • 19:24that would be really cool.
  • 19:25'cause we could determine whether
  • 19:27or not there are megakaryocytes
  • 19:28biased in the iron deficient state,
  • 19:30given that we couldn't get bone
  • 19:32marrow from these patients,
  • 19:33we did the next best thing,
  • 19:35which is to look at Immuring
  • 19:37model of this disease.
  • 19:38So the mooring model of the diseases
  • 19:40that Empress 6 knockout mouse an
  • 19:42we were very fortunate that current
  • 19:44finberg is here at Yale and she
  • 19:46really helped define the temper
  • 19:486 knockout in patients and she
  • 19:49also had the mice.
  • 19:51So Long story short,
  • 19:53temper 6 normally keeps hepcidin levels low.
  • 19:56Low hepcidin levels allow you to absorb iron.
  • 20:00If you have high hepcidin
  • 20:02then you don't absorb any
  • 20:04iron, so Long story short,
  • 20:05our temporal 6 knockout mice do not absorb
  • 20:08iron because their hepcidin levels are high.
  • 20:11And So what we did is we got the temporal
  • 20:146 nicean we looked to see whether they
  • 20:16have microcytic anemia and thrombocytosis,
  • 20:18and they do so with what
  • 20:20I'm showing you here.
  • 20:21Here's the temper 6 knockout.
  • 20:23Here's the wild type.
  • 20:24The hemoglobin is low, the hematocrit is low.
  • 20:26The MCD mean corpuscular volume is low.
  • 20:28So that's why their microcytic their small
  • 20:30red blood cells and the platelet counts
  • 20:32are significantly elevated in these mice.
  • 20:34So the next thing we could do is
  • 20:36look at these mice at their MPs.
  • 20:39So what we did is we fax sorted
  • 20:41out murin megathread progenitors.
  • 20:43And we grew colonies and what you
  • 20:45can see is that the temper 6 knockout
  • 20:48me peas have a megakaryocyte bias,
  • 20:50which is exactly what we predicted.
  • 20:52So this was super exciting to us
  • 20:54and the next thing we did is well,
  • 20:57do they proliferate slower?
  • 20:59And the answer is yes.
  • 21:00So again,
  • 21:01it's consistent with our previous
  • 21:03data that slower cell cycle goes is
  • 21:06consistent with a higher megakaryocyte bias.
  • 21:09We wanted to also study this in human
  • 21:11cells an what we did initially didn't
  • 21:14workout and what we did initially is.
  • 21:16We just tried growing the cells
  • 21:18in the presence of iron chelators
  • 21:21hoping to get a low iron environment
  • 21:23for the cells that would allow
  • 21:25us to see the human cells.
  • 21:27Reiterate these Mooring Dataware
  • 21:29with human me pee when you grew them
  • 21:31in low iron you'd get a Meg bias.
  • 21:34However that didn't workout because
  • 21:35whenever we lowered the iron in
  • 21:38vitro the cells didn't grow colonies
  • 21:40so we ended up instead using.
  • 21:41A more biochemical approach,
  • 21:43which was to knock down TF are two,
  • 21:46so TF are let me just go through back that
  • 21:49there are two different cvars transfusion.
  • 21:53I mean transferrin receptors, there's
  • 21:55transparent Receptor One which is CD 71,
  • 21:57and it's an all proliferating cells and very,
  • 22:01very highly expressed in Eryth roid cells.
  • 22:03And there's transparent receptor 2,
  • 22:05which is entirely different.
  • 22:07Transferrin receptor two
  • 22:08acts more as an iron sensor,
  • 22:10but not as an iron transporter.
  • 22:13And what it does is it binds
  • 22:16to Jolo transparent.
  • 22:17That's transparent,
  • 22:18that has iron bound to it,
  • 22:20and when it's bound to that.
  • 22:24Transparent it activates Erk 1
  • 22:25two and P38 map kinase signaling,
  • 22:28so it's kind of a baseline.
  • 22:30The cells are always expressing
  • 22:31TF R2 they have iron,
  • 22:33they're saying to the MVP.
  • 22:35We got plenty of iron.
  • 22:36Do what you need to do if you
  • 22:39actually have no iron present
  • 22:41so that you have transparent,
  • 22:43but it's not bound to iron then that
  • 22:45Fr two comes off the cell membrane.
  • 22:48It gets internalised and you lose
  • 22:50your Erk 12 signal so it's really an
  • 22:53iron sensor in the presence of it.
  • 22:55It's saying to the cell.
  • 22:56There's plenty of iron available.
  • 22:58Do what you need to do in the absence is
  • 23:00saying wait no eryth roid differentiation.
  • 23:02I'll show you the data
  • 23:04'cause we're low on iron.
  • 23:05So what we do is we knocked down TF are two.
  • 23:08This is just showing you the M RNA
  • 23:10levels are decreased and true enough
  • 23:11when you knock down TF are to the
  • 23:14cells have slower proliferation.
  • 23:15So that told us we might end up seeing
  • 23:17a Meg Bias which is what happened.
  • 23:20So what you're looking at here
  • 23:22is the colony distribution and
  • 23:23non transduced primary human MVP.
  • 23:25Me P transduced with the scrambled
  • 23:27SH RNA and transduced with an SH RNA
  • 23:30against TF are one against TFR 2.
  • 23:32Two different SH RNA's against TF
  • 23:34R2 and in both cases we're seeing
  • 23:36a megakaryocyte bias so this was
  • 23:38consistent with the low iron environment.
  • 23:40Both the mouse and human leading to
  • 23:42a Meg bias Anna slower proliferation
  • 23:44but what's the mechanism of this?
  • 23:47So in order to assess the mechanism
  • 23:49what we did is we went back to
  • 23:52the Meyssan we fax sorted out the
  • 23:54Mega Rich ride for janitors.
  • 23:56And looked at weather.
  • 23:57Looked at the gene expression patterns
  • 24:00between wild type and temper 6
  • 24:02knockout MVP and this work was done
  • 24:05in collaboration with Tomata Baldy
  • 24:07who is does hit our bioinformatics and
  • 24:10what he showed is that there are many
  • 24:13genes that are upregulated when you
  • 24:15knock out temper 6 in these empiezan.
  • 24:17Those tend to be targets of veg F,
  • 24:20whereas there's downregulation of Erk
  • 24:23target genes again consistent with the
  • 24:25idea that you're losing Erk signaling
  • 24:27because the TF R2 would be internalised.
  • 24:30So what we did is we looked in
  • 24:32those MVP's to see if their fasfa
  • 24:35lurk levels were actually decreased
  • 24:37and they were consistent with the
  • 24:39decreased Erk target genes being
  • 24:41phosphorylated and being expressed.
  • 24:42We actually have decreased
  • 24:44or toss work levels.
  • 24:47Similarly, so that was in the mooring system.
  • 24:49Similarly in the human system,
  • 24:51when you knock down the TF R2,
  • 24:53you have decreased phospho, Erk levels.
  • 24:56So the model that we have for what's
  • 24:58going on in this fake decision is that
  • 25:02under normal iron conditions you have
  • 25:04the cells making their decisions to go
  • 25:07down the megakaryocytic versus areth
  • 25:09ride progenitor cell lineages and in
  • 25:11the presence in the case of iron deficiency,
  • 25:14you get anemia at least in part
  • 25:17because you have decreased TF R2.
  • 25:20Which leads to decreased phospho Erk levels,
  • 25:23decreased proliferation and a
  • 25:24megakaryocyte bias which leads you
  • 25:27to have elevated platelet count
  • 25:29and a decrease erythroid count and
  • 25:31the microcytic microcytosis is the
  • 25:33downstream effect of lacking iron
  • 25:35as the erythroid cells are maturing.
  • 25:40So there are a lot of
  • 25:42unanswered questions here and.
  • 25:44Some of them are listed here.
  • 25:46To what extent do me P self renew?
  • 25:49I showed you that me PR this
  • 25:52unique transitional state can
  • 25:54me pee themselves proliferate.
  • 25:56Does cell cycle speed actually
  • 25:58change as cells are about to
  • 25:59undergo their fate specification?
  • 26:01Could we see cells starting to slow
  • 26:03their cell cycle speed in that predicts
  • 26:05there about to pick the megakaryocytic
  • 26:07and speed up their their fate,
  • 26:09their speed up their cell cycle,
  • 26:11and start to pick the erythritol image?
  • 26:14Are there cell characteristics that
  • 26:16predict fate decisions like the
  • 26:19cell size or the cell motility?
  • 26:22What about if we changed the cytokines?
  • 26:24Does that affect fate decisions?
  • 26:26How did cells in the micro
  • 26:28environment affect decisions?
  • 26:29These are all unanswered questions that
  • 26:32we're addressing in our laboratory now in.
  • 26:34This brings me to the beautiful
  • 26:36dynamic system that Vanessa Scanlon
  • 26:38in my laboratory has developed.
  • 26:41So what Vanessa is doing is she is live
  • 26:44image Ng me P as they form colonies.
  • 26:47So she fax or it's out the MVP and
  • 26:49she puts them into semisolid medium,
  • 26:52the same semisolid medium that we
  • 26:54use for a colony forming assays.
  • 26:56It's a collagen based medium.
  • 26:58It's basically mega cult from
  • 27:00stem cell technologies,
  • 27:01and we've added Orris Republican,
  • 27:03and she puts these into an
  • 27:05Olympus Viva view system.
  • 27:07And what this system is is.
  • 27:09It's basically an incubator.
  • 27:10And inside the incubator are these
  • 27:13spots where you can put the dishes.
  • 27:15You can put eight dishes in its hooked up
  • 27:17to a computer an underneath the incubator.
  • 27:20There is a fluorescence camera so
  • 27:22you tell the fluorescence camera
  • 27:23where to take pictures and how
  • 27:25often to take pictures overtime
  • 27:27and you since this is actually an
  • 27:29incubator you can keep them in the
  • 27:31incubator for up to two weeks,
  • 27:33three weeks and really watch
  • 27:35the individual colonies form.
  • 27:36I should mention also that when.
  • 27:39Vanessa was putting this system together.
  • 27:41What she realizes she had to have
  • 27:43some way of flattening the colonies so
  • 27:45that we could watch the cells overtime
  • 27:47and they didn't form a big stick.
  • 27:49Big, thick 3 dimensional colony.
  • 27:51So when she puts the cells in the
  • 27:53first thing she does is she puts him
  • 27:55in about 15 microliters and then
  • 27:57put the cover slip on top of that.
  • 27:59It doesn't affect the distribution
  • 28:01of colony subtypes and it allows
  • 28:03us to see the individual cells.
  • 28:04So what we're seeing here is
  • 28:06a colony with megakaryocytes.
  • 28:07That's the green and erythrocytes in red.
  • 28:10Here's a megakaryocyte only colony,
  • 28:11and here's an Areth Royd Colony.
  • 28:13I left out.
  • 28:14The fact I'm sorry that towards
  • 28:15the end of the culture period,
  • 28:17she adds antibodies against 235 a.
  • 28:19That's like a four and A and CD
  • 28:2141 so that we can identify the
  • 28:23different cell types.
  • 28:24If you add these antibodies
  • 28:26too early in the culture,
  • 28:27then the cells will die.
  • 28:29So there's some phototoxicity
  • 28:30that we really needed to address,
  • 28:32but we're still.
  • 28:32We're still optimizing that,
  • 28:34so we can add the antibodies sooner.
  • 28:37So what I'm going to show you
  • 28:39here is one of the initial images.
  • 28:42Stacked images or movies that
  • 28:43Vanessa was able to get when
  • 28:45she sorted primary human MVP,
  • 28:47put them in culture and
  • 28:49watch them form a colony of
  • 28:51megakaryocytes and erythroid cells.
  • 28:57I'm still here, I just want you to watch.
  • 29:01When you start to see the green color,
  • 29:04that's when she's added
  • 29:05the antibody against E 41,
  • 29:06so those are the megakaryocytes an,
  • 29:08then the pink cells are the ones
  • 29:09that are standing with two,
  • 29:1135 A and those are the erythroid cells.
  • 29:14So the wonderful thing about
  • 29:15having these time lapse images is
  • 29:18that then you can play it back
  • 29:19and forth and actually figure out
  • 29:21which cell divided to Weikum which
  • 29:23other cell type and make a tree.
  • 29:25So here is it.
  • 29:26Tree or lineages tree from a single
  • 29:28by potent megathread for Genitor
  • 29:30and what we've done with these
  • 29:32trees is any cell that was green
  • 29:34at the end or Meg committed at the
  • 29:37end became a green cell at the end.
  • 29:39Any cell at the end? That's red.
  • 29:42That was a rich Rd committed if.
  • 29:44There's a cell that has downstream of it,
  • 29:46some green cells and some red cells.
  • 29:48We call data by Potence Elan, it's blue.
  • 29:52So one of the first things you can
  • 29:54see here is the blue cells can self
  • 29:56renew that me P can self renew so
  • 29:58that had not previously been show.
  • 30:00Phone and now we have that in every
  • 30:02video we have with by potent colonies,
  • 30:05we can see that the MVP themselves
  • 30:07self renew in vitro.
  • 30:08What you can also see is that
  • 30:10there are different patterns.
  • 30:11Sometimes we have a cell that commits to
  • 30:13the erythroid lineages quite early on,
  • 30:15and sometimes it takes much,
  • 30:17much longer to commit to
  • 30:18the erythroid lineage.
  • 30:19Similarly with the megakaryocyte Lenny edge.
  • 30:22We also have colonies that
  • 30:23are eryth roid only.
  • 30:25That came from our sorted me pee
  • 30:26and colonies that are mega only.
  • 30:28They come from our original MVP and
  • 30:30what you can see is initially the.
  • 30:33Cell cycle is relatively slow,
  • 30:35but when it's a erythroid only colony
  • 30:37they get very very fast overtime,
  • 30:39whereas the megakaryocytes or
  • 30:41have a slower colony formation.
  • 30:45So this gave us the opportunity to
  • 30:47address to start to address some of
  • 30:50the many many questions that we have,
  • 30:53and the analysis is on going.
  • 30:55I'll just give you a glimpse as to some
  • 30:58one of the stories that has become more
  • 31:00clear now that we have this dynamic
  • 31:03system of looking at the colonies.
  • 31:06So the dogma that many people believe.
  • 31:09Maybe not.
  • 31:09The folks on this conference on this
  • 31:12web and R is that an Emmy P might
  • 31:15make its fate decision by in the
  • 31:17presence of Thrombo poet and picking
  • 31:19the megakaryocyte Lenny edge and
  • 31:20in the presence of erythropoetin
  • 31:22picking theorist Freud Lenny Edge.
  • 31:24So just to blow that up here that
  • 31:26if we were to grow the cells in
  • 31:28the presence of Thrombo poet and
  • 31:30in the absence of Ipoh we would get
  • 31:33colonies that are only megakaryocyte.
  • 31:34And if we left out the thrombi poet,
  • 31:37and we'd get colonies that are
  • 31:39just eryth roid.
  • 31:41Those of you who know the literature
  • 31:43more deeply might not predict that
  • 31:45something just didn't show up here,
  • 31:47which is the background on this
  • 31:49information background here.
  • 31:50So what I wanted to make sure to tell
  • 31:52you is some of the background as to why.
  • 31:56If you culture the cells in the
  • 31:58presence of minus Devitte Bowen tipo,
  • 32:00you might not predict that this
  • 32:02is what that you would get.
  • 32:04The only in MK only colonies.
  • 32:07So initially what we did is we just
  • 32:09perform static colony forming unit
  • 32:11assays in the presence and absence of
  • 32:14vivo en tipo and the background here
  • 32:16is that we knew that if you don't
  • 32:18have the Erythropoetin Receptor,
  • 32:19you don't form normal Aris Freud Colonies,
  • 32:22but you have some colonies,
  • 32:23so it's not that they can't pick
  • 32:25the fate decision.
  • 32:26It really sounds like it really appears
  • 32:29more that it's a survival signal,
  • 32:31and similarly if you overexpress
  • 32:32the thrombopoietin receptor,
  • 32:33it doesn't cause the cells to just become
  • 32:36megakaryocytes and not a rich way itself.
  • 32:38So we thought there would probably
  • 32:40be more to it and we decided to
  • 32:42test that using this dynamic model.
  • 32:44So the first thing that we did and
  • 32:46this was work that was done by an
  • 32:49undergrad in my lab several years
  • 32:50ago is when we grew the colonies.
  • 32:53In the absence of tipo,
  • 32:54we saw no difference in the
  • 32:56fate specification,
  • 32:56just fewer colonies suggesting
  • 32:58a survival detect.
  • 32:59In contrast,
  • 33:00when we leave out erythropoetin,
  • 33:02we got absolutely no erythroid colonies,
  • 33:04suggesting maybe that it was that
  • 33:06are important is necessary for
  • 33:08the erythroid colonies to grow,
  • 33:10or it was necessary for the fate decision,
  • 33:12but we couldn't tell the difference,
  • 33:15but we've gotten a little smarter since then,
  • 33:18and what we did is instead of just using
  • 33:21CD-235-A as our marker for with Tripoli Sis,
  • 33:24we're using an earlier
  • 33:25marker which is CD71 CD 71,
  • 33:27which is transparent.
  • 33:28Receptor one goes up.
  • 33:30Logarithmically as cells commit
  • 33:31to the erythroid lineage and we
  • 33:33found that if we staying for
  • 33:35CD71 and CD41 instead of 2:35,
  • 33:37but we could actually see that
  • 33:39the cells were committing to
  • 33:41be a Richard Lenny Edge even in
  • 33:43the absence of a riffle poet.
  • 33:45So these are now the data
  • 33:47with this new marker,
  • 33:48the CD 235 a what you're looking at is.
  • 33:51This is a colony that formed both Mega.
  • 33:53These are three different colonies that
  • 33:55formed megakaryocytes and erythroid cells.
  • 33:57Control colony.
  • 33:58Here's one in the absence of Thrombopoietin,
  • 34:00and here's one in the absence of A with
  • 34:02report and see the colonies are much smaller,
  • 34:05but they're still here.
  • 34:06This is the and MK only colony,
  • 34:09and here's a risk.
  • 34:10Weighed only colony, so they all form.
  • 34:12They're just much,
  • 34:13much smaller in the absence of.
  • 34:15Otherwise,
  • 34:15report when we think in retrospect
  • 34:17that this is that the standing
  • 34:20for 235 was really the problem,
  • 34:22but that neither equal nor tipo
  • 34:24affects the fate decision of the MVP,
  • 34:26so we wanted to look at to improve
  • 34:29this further by making a video of
  • 34:31timeless microscopy of colony forming
  • 34:33in the absence of humble poet.
  • 34:35And so this is a colony growing
  • 34:38in the absence of crumble poet,
  • 34:40and you saw that other colony earlier
  • 34:42and it just kept growing and growing.
  • 34:45And what you'll see here is as the cells.
  • 34:48So start to proliferate and form a colony.
  • 34:52Still start to die so you can
  • 34:54see that we picked.
  • 34:55Those red ones are the
  • 34:56erythroid limited sells.
  • 34:57The green ones are the Meg committed cells,
  • 34:59but you're not seeing that same
  • 35:01log Arhythmic expansion itself
  • 35:03because they're starting to die.
  • 35:05And what this is showing us is
  • 35:06that are smaller colonies are not
  • 35:08just due to decreased proliferation
  • 35:10in the absence of from a potent,
  • 35:12but actually do to cell death in
  • 35:14the absence of Fraud Department,
  • 35:15which we wouldn't want otherwise
  • 35:17have been able to see.
  • 35:21Mrs. Just showing you these
  • 35:22colonies side-by-side,
  • 35:23here's a normal colony with
  • 35:24megakaryocytes in erythrocytes,
  • 35:25and here's a colony with that has both
  • 35:28megakaryocytes in a richer sites,
  • 35:30but the vast majority of cells died so that
  • 35:32you didn't get this huge colony expansion.
  • 35:35So our data really have shown quite
  • 35:37nicely that tipo versus EPO do
  • 35:39not affect the MVP fake decision,
  • 35:41so it's negative data,
  • 35:43but it's negative data where we're
  • 35:45starting to get a clue as to the
  • 35:47fact that tipo is necessary for cell
  • 35:49survival and Ipoh is necessary.
  • 35:51For with Droid maturation.
  • 35:54So of course we have a lot of on
  • 35:56going studies looking at whether MVP,
  • 35:59self renew and weather cell cycle speed
  • 36:01predicts subsequent fate decisions,
  • 36:02whether there are other characteristics
  • 36:04that affect cell motility and really
  • 36:06exciting new data that Vanessa is
  • 36:08getting was on the role of cells,
  • 36:10other cells within the micro environment,
  • 36:11and how they affect MVP,
  • 36:13fate specification 'cause all of
  • 36:15our videos to Dayton colonies or
  • 36:17with pure MVP and not with the
  • 36:19other cells that they would be next
  • 36:21to in the bone marrow environment.
  • 36:24So to summarize what I told you today,
  • 36:27single cell RNA seq reveals that
  • 36:30MVP represented unique transitional
  • 36:32state in both primary human cells
  • 36:34and primary mooring cells.
  • 36:36That these MVP are capable of self renewal.
  • 36:39The single cell RNA seq also gave us
  • 36:42a clue that cell cycle differences
  • 36:45between MVP Meg progenitors inner
  • 36:47it's right for janitors are.
  • 36:50Probably playing a role in that
  • 36:51fake decision where the slower cell
  • 36:53cycle promotes a megakaryocyte fate,
  • 36:55whereas a faster cell cycle promotes
  • 36:58in Eryth Roid Fate.
  • 36:59The in vivo timer mice supported
  • 37:01the fact that the MVP or slower
  • 37:04than Meg Progenitors,
  • 37:05which are slower than originally projected.
  • 37:08I showed you data that the iron
  • 37:11content in MVP toggles the MK
  • 37:13versus E fate decision via veg FERK
  • 37:15or signaling and the time lapse
  • 37:18imaging reveals that tipo Niko do
  • 37:21not affect fate decisions per say.
  • 37:24So I've not acknowledge people
  • 37:26as we've gone along,
  • 37:27so I hope that I called on everybody
  • 37:30who was played a role in this work
  • 37:32on may not have mentioned Lee Grimes,
  • 37:35who works with Nathan,
  • 37:37and Lee has also been incredibly
  • 37:39helpful in us with us.
  • 37:40Analyzing the time lapse images
  • 37:42'cause he asks tremendously important
  • 37:44questions that we're now beginning
  • 37:46to address,
  • 37:46which is how likely is it that an MVP
  • 37:49will self renew versus undergoing mag
  • 37:51versus inner. If word fate decision.
  • 37:54Overtime in culture.
  • 37:55I want to mention that my lab
  • 37:57is looking for new postdocs,
  • 37:59so please consider applying and
  • 38:01that this work was also supported
  • 38:03by the Yale Cooperative Center
  • 38:06of excellence in Hematology.
  • 38:08Thank you very much.